Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Depreciation & Amortization (CF): 2011-2022

Historic Depreciation & Amortization (CF) for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2022 value amounting to $586,000.

  • Avadel Pharmaceuticals' Depreciation & Amortization (CF) rose 191.54% to $586,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $1.5 million, marking a year-over-year increase of 83.19%. This contributed to the annual value of $2.7 million for FY2024, which is 51.81% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Depreciation & Amortization (CF) of $586,000 as of Q4 2022, which was up 46.13% from $401,000 recorded in Q3 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Depreciation & Amortization (CF) peaked at $2.0 million during Q1 2018, and registered a low of $197,000 during Q3 2021.
  • In the last 3 years, Avadel Pharmaceuticals' Depreciation & Amortization (CF) had a median value of $290,500 in 2020 and averaged $333,167.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Depreciation & Amortization (CF) crashed by 81.41% in 2019 and then skyrocketed by 191.54% in 2022.
  • Avadel Pharmaceuticals' Depreciation & Amortization (CF) (Quarterly) stood at $1.8 million in 2018, then tumbled by 55.90% to $796,000 in 2019, then crashed by 50.63% to $393,000 in 2020, then slumped by 48.85% to $201,000 in 2021, then soared by 191.54% to $586,000 in 2022.
  • Its Depreciation & Amortization (CF) was $586,000 in Q4 2022, compared to $401,000 in Q3 2022 and $247,000 in Q2 2022.